Journal of Applied Robotics and Artificial Intelligence

Journal of Applied Robotics and Artificial Intelligence

Journal of Applied Robotics and Artificial Intelligence – Editorial Policies

Open Access & Peer-Reviewed

Submit Manuscript

Editorial PoliciesJournal of Applied Robotics and Artificial Intelligence

Integrity for Robotics and AI Publishing

JRAI maintains clear policies to protect research quality and clinical trust.

Editorial Independence

Editorial decisions are based on scientific merit, clinical relevance, and ethical compliance. APC payments do not influence outcomes.

Peer Review Standards

JRAI uses independent expert review focused on methodology, validation quality, and clinical impact.

Ethics and Research Integrity

Submissions are screened for plagiarism and ethical compliance. Concerns are addressed through documented procedures.

Conflicts of Interest

Authors, editors, and reviewers must disclose conflicts. Transparency protects patient safety and research integrity.

Corrections and Retractions

If errors are identified after publication, JRAI issues corrections or retractions to preserve the scholarly record.

Publishing Standards: Rigorous peer review, ethics oversight, DOI registration, open access distribution, and long term archiving for robotics, AI, and surgical innovation research.

Publish with Integrity

Submit with confidence knowing your work is evaluated through rigorous ethical standards.

Submit via ManuscriptZoneView APC Details

Email: [email protected]

Clinical and Engineering Impact

JRAI focuses on research that advances patient outcomes and technical performance. We emphasize reproducible methods, transparent reporting, and practical implementation insights for robotics and AI systems in surgery and healthcare.

Author Support

The editorial office provides guidance on scope, formatting, and compliance so research teams can move efficiently from submission to publication. Clear communication helps interdisciplinary teams align technical and clinical expectations.

Appeals and Complaints

Authors may appeal decisions with evidence based responses. Complaints are reviewed transparently by the editorial office.

Data Verification

Editors may request data or documentation to resolve questions about reliability or reproducibility.

Authorship Criteria

All listed authors must meet accepted authorship criteria and approve the final manuscript. Contribution statements help clarify individual roles and responsibilities.

Clinical Trial Registration

Prospective clinical trials should be registered in a recognized registry. Registration details should be included in the manuscript.

Research Ethics

Human and animal studies require ethics committee approval and informed consent where applicable. Missing documentation may result in desk rejection.

Data Availability

Authors should include a data availability statement describing how supporting data can be accessed or why restrictions apply. Transparency supports reproducibility.

Corrections and Retractions

If post publication issues arise, the journal may issue corrections, expressions of concern, or retractions to preserve the scholarly record.

Reviewer Conduct

Reviewers must maintain confidentiality, disclose conflicts, and provide constructive feedback. The editorial office monitors adherence to these standards.

Image and Content Integrity

Submissions are screened for originality and image integrity. Concerns are addressed according to documented procedures.

Peer Review Model

JRAI uses independent expert peer review with clear evaluation criteria. Editors ensure reviews remain objective, constructive, and focused on scientific merit.

Confidentiality

Submitted manuscripts and reviewer reports are confidential. Editors and reviewers must not share content outside the review process.

Misconduct Handling

Allegations of misconduct are investigated following documented procedures. The journal cooperates with institutions when formal inquiries are required.

Decision Transparency

Decision letters summarize key review points and specify required revisions. Transparent communication helps authors respond effectively.

Post Publication Review

If new concerns arise after publication, the editorial office evaluates evidence and issues updates as needed to protect the record.

Policy Updates

Editorial policies are reviewed regularly to align with evolving standards in robotics, AI, and clinical research. Updates are communicated to editors and reviewers.

Human Subject Protections

Manuscripts involving human participants must document consent, privacy safeguards, and ethics approval. Failure to meet these requirements may result in rejection.

Data and Code Ethics

Authors should disclose data provenance, usage permissions, and potential bias sources. Ethical data practices improve trust in AI outcomes and robotic systems.

Publication Ethics Training

Editors and reviewers are encouraged to follow ethics guidance and best practices to maintain consistent and fair decision making.

Appeal Process Timeline

Appeals should be submitted with supporting evidence and a concise response to reviewer comments. The editorial office will review appeals promptly and communicate next steps.

Claims and Overstatement

Authors should avoid overstating clinical performance or regulatory readiness. Clear limitations and evidence based claims protect patient safety and scientific credibility.

AI Model Transparency

Authors should describe model training data, validation strategies, and limitations, including bias assessment and performance across subgroups. Clear reporting supports reproducibility, appropriate clinical interpretation, and safer deployment of robotic and AI systems.

Conflict of Interest Disclosure

All authors, editors, and reviewers must disclose financial or non financial interests that could influence judgment, including industry ties, patents, or advisory roles. Disclosures are published with accepted articles to maintain transparency.

Regulatory Context

Submissions should distinguish research findings from regulatory approval status and cite applicable guidance when discussing clinical deployment. This reduces ambiguity for readers.